Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
89,596,633
-
Share change
-
+740,704
-
Total reported value
-
$6,383,418,413
-
Put/Call ratio
-
66%
-
Price per share
-
$71.41
-
Number of holders
-
320
-
Value change
-
-$95,226,490
-
Number of buys
-
159
-
Number of sells
-
200
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2018
As of 31 Dec 2018,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
320 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,596,633 shares.
The largest 10 holders included
FMR LLC, JANUS HENDERSON GROUP PLC, Vanguard Group Inc, BlackRock Inc., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, BB BIOTECH AG, Invesco Ltd., and FRANKLIN RESOURCES INC.
This page lists
320
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.